当前位置: 首页 > 期刊 > 《《新医学导刊》》 > 2008年第7期
编号:11731484
硫酸镁与酚妥拉明复合注射液治疗肺心病难治性心衰的疗效观察
http://www.100md.com 2008年7月1日 《新医学导刊》 2008年第7期
硫酸镁与酚妥拉明复合注射液治疗肺心病难治性心衰的疗效观察

     中图分类号:R541.5

    文献标识码: A

    文章编号: 1672-3783(2008)-7-0019-02

    【摘 要】目的 观察用硫酸镁与酚妥拉明复合注射治疗肺心病难治性心衰的临床效果。方法 将87例患者分为治疗组(47例)和对照组(40例),两组常规治疗相同,治疗组加用硫酸镁与酚妥拉明复合注射液静脉滴注,疗程7-10天。结果 治疗组和对照组的临床症状和体征改善的有效率分别为93.6%和75%(P<0.05)。结论 使用硫酸镁与酚妥拉明复合注射液静脉滴注治疗肺心病难治性心衰有显著疗效。

    【关键词】硫酸镁与酚妥拉明复合注射液 肺心病 难治性心衰

    Observation on the Curative Effect of Magnesium Sulphate

    and Phentolamine Compound Injection in the Treatment

    of Intractable Heart Failure in pulmonary Heart Disease

    ZHANG Guo-wei,XU Di

    Dianbai County People’s Hospital,Dianbai 525400 ,Guangdong, China

    【Abstract】Objective To observe the clinical effect of Magnesium Sulphate and Phentolamine Compound Injection in the treatment of intractable heart failure in pulmonary heart disease.MethodA total of 87 cases patients were divided into treatment group of 47 cases and control group of 40 cases. The regular treatment in two groups is the same and intravenous drip of Magnesium Sulphate and Phentolamine Compound Injection had been used in treatment group, 7-10 days for one course of treatment. ResultThe effective rates in the improvement of clinical symptoms and sign in treatment group and control group were respectively 93.6% and 75% (P<0.05).Conclusion It is very effective that the intractable heart failure in pulmonary heart disease is treated by the intravenous drip of Magnesium Sulphate and Phentolamine Compound Injection. ......

您现在查看是摘要页,全文长 5674 字符